Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...
Sanofi has returned to U.S. artificial intelligence research biotech Earendil Labs for another significant autoimmune and ...
Pharmaceutical Technology on MSN
Sanofi and Earendil Labs forge $2.56bn autoimmune deal
GlobalData analyst Vasilis Roumpelakis notes that bispecifics could hold strong potential in the future, but manufacturing ...
Augurex CEO Neil Klompas shares how the company is changing the way autoimmune diseases are diagnosed in this episode of ...
The collaboration with Sanofi focuses on developing bispecific antibodies for autoimmune diseases, leveraging predictive ...
A phase 3 study of Zenas BioPharma's autoimmune disease candidate has hit its primary endpoint. But, with the result falling ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 ...
Scientists from the Institute of Molecular Genetics of the Czech Academy of Sciences, in collaboration with the Faculty of ...
Jade Biosciences ( ($JBIO) ) has issued an announcement. On January 5, 2026, Jade Biosciences announced its 2026 strategic priorities ahead of the ...
In today’s Pharmaceutical Executive Daily, the Wegovy Pill becomes the first available oral GLP-1 for weight management, ...
Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback